about
sameAs
P1050
Vaccines against malariaSystematic review and meta-analysis: rapid diagnostic tests versus placental histology, microscopy and PCR for malaria in pregnant womenA systematic review of the safety and efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria during pregnancyA fresh look at the origin of Plasmodium falciparum, the most malignant malaria agentClinical review: Severe malariaSpread of artemisinin resistance in Plasmodium falciparum malariaChallenges of drug-resistant malariaArtemisinin-resistant malaria: research challenges, opportunities, and public health implicationsBiochemical and immunological mechanisms by which sickle cell trait protects against malariaPlasmodium falciparum erythrocyte invasion: combining function with immune evasionSafety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic reviewInvasion by P. falciparum merozoites suggests a hierarchy of molecular interactionsArtemisinin-naphthoquine for treating uncomplicated Plasmodium falciparum malariaPrimaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmissionArtemether for severe malariaPrimaquine or other 8-aminoquinoline for reducing P. falciparum transmissionArtesunate plus pyronaridine for treating uncomplicated Plasmodium falciparum malariaDihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malariaIntermittent presumptive treatment for malariaHemoglobinopathies: slicing the Gordian knot of Plasmodium falciparum malaria pathogenesisIntrarectal quinine for treating Plasmodium falciparum malaria: a systematic review.Challenges for malaria elimination in BrazilPlasmodium malaria and antimalarial antibodies in the first year of lifePlasmodium falciparum and soil-transmitted helminth co-infections among children in sub-Saharan Africa: a systematic review and meta-analysisThe Link between Plasmodium falciparum Malaria and Endemic Burkitt's Lymphoma-New Insight into a 50-Year-Old EnigmaNew Concepts in Malaria Pathogenesis: The Role of the Renin-Angiotensin SystemImmunoregulation in human malaria: the challenge of understanding asymptomatic infectionThe malaria parasite cation ATPase PfATP4 and its role in the mechanism of action of a new arsenal of antimalarial drugsArtemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient dataClinical determinants of early parasitological response to ACTs in African patients with uncomplicated falciparum malaria: a literature review and meta-analysis of individual patient dataAssociation between anthropometry-based nutritional status and malaria: a systematic review of observational studiesFalciparum malaria molecular drug resistance in the Democratic Republic of Congo: a systematic reviewSeasonality of Plasmodium falciparum transmission: a systematic reviewThe Emerging Role for RNA Polymerase II in Regulating Virulence Gene Expression in Malaria ParasitesMonitoring of efficacy and safety of artemisinin-based anti-malarials for treatment of uncomplicated malaria: a review of evidence of implementation of anti-malarial therapeutic efficacy trials in TanzaniaPlasmodium falciparum parasites lacking histidine-rich protein 2 and 3: a review and recommendations for accurate reportingPharmacokinetic and pharmacodynamic considerations in antimalarial dose optimizationGenetic polymorphisms linked to susceptibility to malariaDrug resistance genomics of the antimalarial drug artemisininCombination of probenecid-sulphadoxine-pyrimethamine for intermittent preventive treatment in pregnancy
P921
Q189522-726E0C12-2555-4844-ACC9-215C1D3CC422Q27279400-2FE533E4-F9C4-4248-AA1D-EB3ACC522721Q411557-3D9E7A99-9AAC-4771-9DAC-043C898B2241Q411557-EE68744E-5BC5-406C-847C-51EB135583E6Q417208-7A134532-718E-48B7-896E-C89F11F8D977Q419834-1C45B71F-A8FC-44F4-ABF4-8E5239ABED30Q420607-51E440C1-FCE1-4FCE-ADD7-79CD69C58EB6Q420607-6CC304D9-E0B8-4535-8716-72B2CFB51FA8Q421072-9BF945B9-BCA3-4184-A401-E065F800B60EQ422438-BD294C49-C801-4B36-8DD5-7BE1501F0DFDQ736270-7E210930-DD2C-482A-A416-2AA0FE1945EEQ947595-57FA9150-7058-40BF-BA1C-3EFC7EE3CE3AQ947595-76CECE93-0611-459C-AA53-43037717B78E
P2175
Q17485685-82B4D2D8-B91E-45EA-9BC6-E1E3FD23A2BAQ17485686-EF0802AE-E2DF-4808-B333-7E8997B18796Q17485688-26CE5DDB-67F5-4998-886B-79D742FF645DQ17485690-E85962CC-6A7B-447E-9D0A-2A46F5A0C40AQ17485691-FE3411E8-9520-40AC-9E70-19A5FFA40FFBQ21032481-a270b226-4268-e1b3-057c-e22060bb0543Q21032482-74C94B55-69D2-4987-8D69-D3585C0902DFQ21032532-909AC481-6AF7-4EFA-A6CC-C2AA9F40FADDQ21034104-6AADB2B1-6316-47D3-BCCD-4AD52D545FACQ21131363-86CCDC84-8A09-4940-B910-77E8193A088DQ21133667-1788C832-DD94-465C-A080-3F1DE1B9EEA3Q21559521-AE008530-0103-43AA-A3D3-F7DA475A4CECQ24188020-F8F41EDA-1D81-4F27-81CD-8773127EE702Q24188070-D81D3BD3-34DE-4CB2-95EB-8BA73CC9E9EBQ24193663-45FF8407-A407-4B74-9AC1-5AAC1995E496Q24193716-3E139E57-4A13-4065-9ED8-76D1A418BAC5Q24198103-A57D5078-50A3-4E15-A498-C2EA5839D6A7Q24201077-19F2B0BD-5A67-4FD6-ABAD-20F6B2111142Q24809091-5FC3783B-E07C-4366-9B4D-3AD2DB894B25Q24810377-AC482E0D-CFA9-4A07-A7B4-40C09CD210EDQ24811390-B450DAFA-6A18-43B1-8120-D9D5A3F15893Q26315456-44D903ED-1D99-43B1-B0F8-FA00DECF298EQ26315542-8401D470-8909-4F40-8E43-E10081FED4CEQ26745828-357D4C41-3041-4684-9EDD-D383B2C27FC5Q26770184-24136FD1-6E38-44E7-BE0A-1BA6F7FAEC73Q26771362-648188A6-6D03-4CE7-9742-CF0A9E830B8CQ26775212-1368684C-AE55-433A-BDAE-2FC0D25EBD7EQ26781634-B03D76AB-F4D5-424B-8EBE-6531E84E0CF2Q26783646-8F57E62F-0A5D-4456-A4BA-991E648ED03EQ26783902-12702221-9325-4DDB-A723-3851A23E0C34Q26786117-E6FE8055-D16E-4FAD-9DD0-A6AB6F65540DQ26786140-C23FFA46-F210-4195-9C0D-C5C1ED04B222Q26787055-6168ECA1-F38F-4A97-82C5-F60FB6EE2A74Q26800263-2FC79E1A-5529-4653-80EB-E9DE977B019AQ26820807-CAAD21AC-072B-4DC2-8A3E-88D0C7B5A2C9Q26825023-37923AC6-8019-4C59-AF1D-B4291906E291Q26830528-DE2E9420-F9E0-4444-8729-742FA3359421Q26860744-BD1B7A6E-73B4-48B7-95AD-352B18F32CA0Q26862789-EE056238-9B45-4E77-973D-9F72B4570FDBQ27005614-93E5CF0A-32AD-44D2-96E1-B99F3BC67CC7
P921
description
Krankheit
@de
forme la plus fréquente et la plus grave de paludisme
@fr
malaria described as a severe ...... prolonged or continuous fever
@en
name
Plasmodium falciparum malaria
@en
Plasmodium falciparum-malaria
@nn
malaria, Plasmodium falciparum-ak sortua
@eu
paludisme per Plasmodium falciparum
@ca
paludisme à Plasmodium falciparum
@fr
paludismo por Plasmodium falciparum
@es
type
label
Plasmodium falciparum malaria
@en
Plasmodium falciparum-malaria
@nn
malaria, Plasmodium falciparum-ak sortua
@eu
paludisme per Plasmodium falciparum
@ca
paludisme à Plasmodium falciparum
@fr
paludismo por Plasmodium falciparum
@es
altLabel
Falciparum Malaria
@en
Falciparum malaria (disorder)
@en
Falciparum malaria [malignant tertian]
@en
Falciparum-malaria
@nn
Malaria fever, subtertian
@en
Malaria, Falciparum
@en
PLASMODIUM FALCIPARUM BLOOD INFECTION LEVEL
@en
Pfbi
@en
Plasmodium Falciparum Parasitemia
@en
Plasmodium falciparum blood infection level
@en
prefLabel
Plasmodium falciparum malaria
@en
Plasmodium falciparum-malaria
@nn
malaria, Plasmodium falciparum-ak sortua
@eu
paludisme per Plasmodium falciparum
@ca
paludisme à Plasmodium falciparum
@fr
paludismo por Plasmodium falciparum
@es
P2176
P2892
P486
P1417
science/falciparum-malaria
P1748
P1995
P2176
P279
P2888
P2892
P486
P492
P5270
MONDO:0005920
MONDO:0009553
P672
C01.610.752.530.650
C01.920.875.650
P699
DOID:14067